ADAMA reports strong growth, driving record sales in both the Q3 and year-to-date
Overcoming significant headwinds throughout the year
 Q3 record-high sales of$953 million, growing+9% in US dollar terms,+11% in local currencies
‒ Strong business growth in almost all geographies, led by robust recovery in North America, strong performance in Latin America and Europe
‒ Continued average price increases of more than2% across all regions
‒ Q3 sales constrained by$55 million due to Jingzhou old site disruption impacting supply of high-demand products; incremental ramp-up of production at site continuing
‒ 9M record-high sales of$2,962 million, exceeding lastyear’s in both US dollar terms and local currencies, overcoming the significant market and supply headwinds encountered throughout the year, as well as the impact of softer currencies
‒ Jingzhou old site disruption constraining 9M sales by$162 million
‒ Sales of formulated, branded products in China, other than those from the Jingzhou old site, grew by more than25% in both the quarter and the nine-month period
 Q3 Gross Profit up6% to$295 million
‒ Gross margin of31.0% vs.32.0% last year
‒ 9M gross profit of$968 million, with gross margin of32.7% vs.33.3% last year
‒ Increased prices offset by higher procurement costs and softer currencies
‒ Jingzhou old site disruption constraining Q3 gross profit by$24 million and 9M gross profit by$64 million
 Q3 EBITDA up8% to$144 million
‒ EBITDA margin of15.1%, in-line with last year
‒ 9M EBITDA of$509 million, in-line with last year; EBITDA margin of17.2%, in-line with last year
‒ Strong containment of operating expenses despite recording idleness cost at Jingzhou old site
‒ Jingzhou old site disruption, including idleness cost, constraining Q3 EBITDA by$31 million and 9M EBITDA by$89 million
 Q3 Net Income of$42 million,5% above last year
‒ Net income margin of4.4% vs.4.6% last year
‒ 9M net income of$173 million, with net income margin of5.9% vs.6.8% last year
‒ Jingzhou old site disruption, constraining Q3 Net Income by$25 million and 9M Net Income by$71 million
BEIJING, CHINA and TEL AVIV, ISRAEL, October 30, 2019– ADAMA Ltd. (the “Company”) (SZSE 000553) today reported its financial results for the third quarter and nine-month period ended September 30, 2019.
Table 1. Financial Performance Summary
||
|-|
|Adjusted, US$m|

|||||
|-|-|-|-|
||||%|
|||%||
|Q3 2019|Q3 2018||Change|
|||Change||
||||CER|

|||||
|-|-|-|-|
||||%|
|9M|9M|%||
||||Change|
|2019|2018|Change||
||||CER|

 Revenues 953 872 +9% +11% 2,962 2,918 +2% +3% Gross profit 295 279 +6% 968 972 -0.4% Gross margin 31.0% 32.0% 32.7% 33.3%
Operating income (EBIT) 83 81 +3% 325 353 -8% EBIT margin 8.7% 9.3% 11.0% 12.1%
Net income 42 40 +5% 173 197 -12% Net income margin 4.4% 4.6% 5.9% 6.8%
EBITDA 144 134 +8% 509 512 -0.6% EBITDA margin 15.1% 15.3% 17.2% 17.6%
Earnings per share - USD 0.0173 0.0164 0.0708 0.0806
- RMB 0.1210 0.1117 0.4836 0.5200
All income statement items contained in this release are presented on an adjusted basis. A detailed description and analysis of differences between the adjusted income statement and that reported in the financial statements is contained in the “Analysis of Gaps between Adjusted Income Statement and Income Statement in Financial Statements” in the appendix to this release. EPS are the same for basic and diluted. Q3 and 9M 2019 include the results of both Bonide and Anpon following their acquisition in Q1 2019.
Commenting on the results, Yang Xingqiang, Chairman ofADAMA’s Board of Directors, said, “Our strong performance in the quarter aided in overcoming the challenges that we faced during the first-half of the year, bringing the Company to growth also over the nine-month period. With the continued development and rolling out of our pipeline of differentiated products in markets across the globe, we remain focused on executing our growth strategy and look ahead to concluding the year with positive momentum.”
Chen Lichtenstein, President and CEO of ADAMA, added, “We delivered record-high sales in both the quarter and nine-months, led by double-digit growth in North America as well as our differentiated, formulated and branded products in China. Latin America is performing strongly as it goes into its peak season, and we saw a pleasing contribution from Europe in its late season. The business growth was further bolstered by continued price increases. This performance drove growth in all profit-metrics in the quarter, despite the significant residual impact from the Jingzhou site disruption which is continuing to progress in its ramp-up of operations.”
Performance in Context of Market Environment
The third quarter saw drought conditions across Europe, Latin-America and parts of Asia-Pacific. In Europe, the dry weather delayed herbicide application in key crops and reduced oilseed rape planting areas. North America saw a partial recovery late in the season following the severe flooding
seen in the first half of the year. Following a delayed start to the Indian monsoon season, conditions
have improved.
Prices in key crops including wheat, corn and soybean softened somewhat during the quarter, which
continues to challenge farmer income in most regions.
While product supply remains generally constrained due to the increased environmental focus in China causing industry-wide shortages in certain raw materials and intermediates, some capacity is returning to the market, yet procurement costs are still elevated compared to last year. The Company continues to raise its prices in all regions and contain its manufacturing and other operating costs to mitigate this impact.
Financial Highlights
Revenues in the third quarter grew strongly to$953 million, up9% compared to$872 million in the same period last year in US dollar terms, and11% up in constant currency terms. Nine-month sales reached$2,962 million, up2% in US dollar terms compared to$2,918 million in the parallel period last year, and up3% in constant currency terms, overcoming the significant headwinds encountered throughout the year. This strong growth was achieved despite the impact of the disruption at the Jingzhou old site, which constrains the supply of high-demand products in many geographies as it continues its gradual ramp-up of operations. The disruption at the site constrained third quarter sales by$55 million and nine-month sales by$162 million.
The third quarter saw a partial recovery in North America late in the season following the severe weather challenges seen in the first half of the year, with noteworthy performances in both the US and Canada. The Company also grew strongly in Europe in the third quarter, following a challenging first half of the year, despite the drought in the region, as well as in Brazil and the rest of Latin America, where its portfolio of differentiated products is driving increasing market penetration. In China, ADAMA continues to grow sales of its differentiated, formulated and branded products at significant double-digit rates.
Supportive demand facilitated further price increases in the quarter of an average2% across all regions.
Gross profit grew6% in the third quarter to$295 million (gross margin of31.0%) compared to$279 million (gross margin of32.0%) in Q3 2018, while gross profit in the nine-month period was$968 million (gross margin of32.7%), in line with the$972 million (gross margin of33.3%) recorded in the corresponding period last year. The somewhat lower gross margins reflect the impact of the Jingzhou old site disruption which constrained sales of backward-integrated products in high demand, as well as higher procurement costs and softer currencies, partially offset by higher pricing aimed at passing on the impact of the higher procurement costs, as well as an improvement in product mix in the quarter. The Jingzhou site disruption reduced third quarter gross profit by$24 million and nine-month gross profit by$64 million.
Operating expenses. Total operating expenses in the third quarter were$212 million(22.3% of sales) compared to$198 million(22.7% of sales) in Q3 last year, and$643 million(21.7% of sales) in the nine-month period compared to$618 million(21.2% of sales) in the corresponding period last year. The tight expense-to-sales ratios in both the quarter and in the nine-month period reflects the ongoing strong containment of expenses, and was achieved despite the inclusion of joiners and the recording of Jingzhou old-site related idleness costs of$8 million in the quarter and$29 million in the nine-month period. Operating expenses also benefited from the stronger US dollar as well as, in the first half of the year, income from expropriation of land.
Sales and Marketing expenses in the third quarter were$148 million(15.5% of sales), and$472 million(15.9% of sales) in the first nine months, compared to$146 million(16.8% of sales) and$465 million(15.9% of sales) in the corresponding periods last year, respectively. The improvement in the expense-to-sales ratio in the quarter, and its stability in the nine-month period, largely reflects the containment of expenses, and was achieved despite the inclusion of joiners.
General and Administrative expenses in the third quarter were$32 million(3.4% of sales), and$101
million(3.4% of sales) in the first nine months, compared to$30 million(3.4% of sales) and$103
million(3.5% of sales) in the corresponding periods last year, respectively, achieved despite the inclusion of joiners, and reflects the strong containment of expenses.
R&D expenses in the third quarter were$15 million(1.6% of sales), and$46 million(1.6% of sales) in the first nine months, compared to$16 million(1.8% of sales) and$40 million(1.4% of sales) in the corresponding periods last year.
Operating income in the third quarter was$83 million(8.7% of sales) and$325 million(11.0% of sales) in the first nine months, compared to$81 million(9.3% of sales) and$353 million(12.1% of sales) in the corresponding periods last year, respectively. The Jingzhou old site disruption, including idleness costs, constrained operating income by$31 million in the third quarter and by$89 million in the nine-month period.
EBITDA in the third quarter was$144 million(15.1% of sales), up8% compared to the$134 million(15.3% of sales) recorded in Q3 2018. In the nine-month period, EBITDA was$509 million(17.2% of sales), in line with the$512 million(17.6% of sales) recorded in the corresponding period last year. The Jingzhou old site disruption, including idleness costs, constrained EBITDA by$31 million in the third quarter and by$89 million in the nine-month period.
Financial expenses and investment income. Total net financial expenses and investment income were$35 million in the third quarter and$122 million in the first nine months, compared to$30 million and$97 million in the corresponding periods last year, respectively. The higher level reflects mainly higher hedging costs due to global currency volatility, as well as higher interest payments, offset in the third quarter by the reduction in financing costs on the ILS-denominated, CPI-linked bonds due to a lower CPI. The lower expenses in the corresponding periods last year reflect the benefit of foreign exchange income related to balance sheet positions.
Tax expenses. Net tax expenses were$6 million in the third quarter and$30 million in the first nine months, compared to$11 million and$60 million in the corresponding periods last year, respectively. The lower net tax expenses in the quarter reflect the impact of the Jingzhou old site disruption, which reduced taxable income, partially offset by a non-cash impact due to the devaluation of the Brazilian Real over the quarter, which reduced the value of local currency-denominated non- monetary assets. The lower tax expenses over the nine-month period were largely due to the lower taxable income, mainly resulting from the impact from the Jingzhou old site disruption, as well as changes in exchange rates against the US dollar that affected the value of local-currency denominated balance sheet items.
Net income in the third quarter was$42 million(4.4% of sales) up5% compared to the$40 million(4.6% of sales) recorded in Q3 2018. In the nine-month period, net income was$173 million(5.9% of sales), compared to$197 million(6.8% of sales) in the corresponding period last year. The Jingzhou old site disruption constrained net income in the quarter by$25 million and in the nine- month period by$71 million.
Working capital at September 30, 2019 was$2,143 million, compared to$1,751 million at the same point last year. The higher level reflects increased trade receivables resulting from theCompany’s robust performance in Brazil in the first nine months, alongside somewhat lower payable days. In addition, inventory levels were higher due to the higher procurement costs, changes in the sales mix due to the volatile weather in many regions, proactively constrained sales due to credit restraint in Eastern Europe, as well as the first-time inclusion of joiners.
Cash Flow. Operating cash flow of$57 million was generated in the quarter and$10 million in the first nine months, compared to$99 million and$221 million generated in the corresponding periods last year, respectively, mainly reflecting the build-up of working capital earlier in the year and the
impact of the disruption from the Jingzhou old site, which is now gradually ramping-up its operations.
Net cash used in investing activities was$42 million in the quarter and$245 million in the first nine- months compared to$44 million and$85 million in the corresponding periods last year, respectively. Investing activities in the quarter include increased investments in the relocation and upgrading of environmental facilities in Jingzhou, as well as proceeds from expropriation of land. The higher nine- month investment level also reflects acquisitions made during the year. In the first quarter of 2018, the Company recorded the one-time proceeds from the divestiture of several products in connection with the approval by the EU Commission of the acquisition of Syngenta by ChemChina, and outflow of a lesser net amount for the transfer of a similar portfolio of products.
Free cash flow of$7 million was generated in the third quarter, while$290 million was consumed in the nine-month period. This compares to the$52 million and$93 million that the Company generated in the corresponding periods last year, respectively, noting the impact of net proceeds from divestitures in 2018, and acquisitions in 2019.
Leverage: Balance sheet net debt at the end of the quarter was$960 million, compared to$435 million as of September 30, 2018, largely reflecting the acquisitions and the assumption of their debt, capital investments and dividends paid.
Corporate development
ADAMA today also announced the acquisition of AgroKlinge, a leading Peruvian crop protection company. This acquisition will allow ADAMA to further improve and expand its business in Peru, broadening its portfolio, creating a leading commercial platform throughout the country and enhancing its access to large scale industrial farmers.
Increasing collaboration activities
The Company continues to advance collaboration opportunities with other ChemChina group entities, as well as other entities of the Sinochem group, to make the most of its positioning.
Jingzhou Old Site
Following resumption of operations at the Jingzhou old site in late March, the Company continues to advance the gradual ramp-up of production at the site. The site was visited during the third quarter by the Ecological Protection Supervision Team of the central government, as part of its inspections of the ChemChina group and in the context of strengthening ongoing nationwide environmental focus. As part of its Chinasites’ three-year relocation and upgrade process, due to conclude by the end of next year, the Company continues to work with all relevant authorities to bring the site to best-in-class safety and environmental standards.
In a significant milestone in this upgrade and relocation process, ADAMA obtained a new, expanded EIA (Environmental Impact Assessment) permit for the new Jingzhou site, allowing increased production of Acephate, DMPAT and other backward-integrated products. This will ensure theCompany’s ability to strengthen theACEMAIN® franchise in key markets, including India, Brazil, US and China, leveraging its strong cost position and site stability.
By end of 2020, ADAMA is aiming to complete most of its relocations at both Jingzhou andHuai’An, vacate the old sites, and be operational with improved cost and efficiencies at its new sites. The transformed new sites are designed to be more profitable, and ready to accommodate additional new molecules emerging from theCompany’s strong development pipeline.
Table 2. Regional Sales Performance
|||||
|-|-|-|-|
|Q3 2019|Q3 2018|Change|Change|
|$m|$m|CER|USD|

|||||
|-|-|-|-|
|9M 2019|9M 2018|Change|Change|
|$m|$m|CER|USD|

 Europe 188 168 +15.0%+12.1% 816 870 -8.1% -6.2% North America 160 124 +28.8%+28.8% 560 530 +5.7% +5.5% Latin America 302 277 +10.1% +9.1% 657 587+16.7%+11.9% Asia Pacific 138 131 +8.6% +5.3% 496 487 +6.1% +1.9% Of which China 76 69 +13.0% +9.8% 255 241 +9.3% +5.6% India, Middle East& Africa 166 173 -3.4% -4.0% 432 443 +2.3% -2.4% Total 953 872 +10.8% +9.3% 2,962 2,918 +3.4% +1.5% CER: Constant Exchange Rates
Europe: Sales in Europe grew by15.0% in the quarter and were lower by8.1% in the first nine- months, in constant currency terms, compared to the corresponding periods last year. The strong performance in the quarter was driven by business growth, although only partially recovering from the supply-related challenges in the first half of the year, and despite a severe drought in the region which delayed herbicide application in cereals, reduced disease pressure in grapes and citrus, lowering consumption, and reduced oilseed rape planting areas.
In Northern Europe, sales grew strongly in the quarter driven by Germany and the Baltic countries. The Company restrains sales in Ukraine where liquidity remains challenging for distributors. The Company saw robust growth in South Europe in the quarter with continued market share gains. Noteworthy performances were recorded in France, which experienced its second strongest harvest on record, as well as Italy and Iberia. Strong demand for insecticides compensated for the weak disease pressure in grapes and citrus.
The Company obtained a number of new registrations for differentiated products, includingFOLPAN®,ADAMA’s proprietary fungicide treating key resistant diseases in cereals in Germany,PITCHER®, a differentiated mixture fungicide for flower-bulbs in the Netherlands and ZAKEOEXTRA®, a dual-action, wide spectrum fungicide in Greece.
In US dollar terms, sales in Europe grew by12.1% in the quarter and were lower by6.2% in the first nine months, compared to the corresponding periods last year, reflecting the impact of softer currencies over the periods.
North America: Sales grew by28.8% in the quarter and by5.7% in the nine-month period, in constant currency terms, compared with the corresponding periods last year. The significant increase in the quarter was achieved through a combination of robust organic business growth, increased prices and joiners.
The Company recorded strong growth in the quarter in both the US and Canada, partially recovering from the first-half floodings while benefiting from price increases in key backward- integrated products.
In US dollar terms, sales in North America grew by28.8% in the quarter and5.5% in the first nine months, compared to the corresponding periods last year.
Latin America: Sales grew by10.1% in the quarter and by16.7% in the first nine months, in
constant currency terms, compared to the corresponding periods last year. Strong business growth
in key countries in the face of a severe drought across the region, alongside continued price
increases, more than offset the impact of constrained supply.
The Company continues to grow strongly in Brazil despite a delayed planting season in soybean
and corn crops, driven by its differentiated product portfolio and key recently launched products.
These include flagship productCRONNOS®, the triple-action fungicide for soybean rust which is performing strongly in its first year since launch,GALIL®, a differentiated combination insecticide andTRIVOR®, a dual-action insecticide for rapid and extended control of sucking pests.
Noteworthy performances were recorded in the quarter in Colombia, Bolivia, Mexico and Peru, while over the nine-month period, the leading contributors to growth were Peru and Colombia. During the quarter, ADAMA launched several new products, includingBREVIS®, a differentiated solution to optimize fruit load and size in apples in Argentina andTRIVOR®, in Colombia. The Company obtained a number of new registrations for differentiated products, includingEXPERTGROW®, a range of biostimulants promoting the growth and development of multiple fruit, vegetables and flower crops in Peru, Paraguay and Bolivia.
In US dollar terms, sales in Latin America increased by9.1% in the quarter and11.9% in the first nine months, compared to the corresponding periods last year, reflecting the impact of generally softer currencies, and in particular the devaluation of the Argentinian Peso.
Asia-Pacific: Sales in the region grew by8.6% in the third quarter and by6.1% in the first nine months, in constant currency terms, compared to the corresponding periods last year, driven by business growth alongside continued price increases, while being affected by constrained supply of products of the Jingzhou old site.
In China, ADAMA continues to see strong demand for its differentiated, formulated and branded products, with sales growth of more than25% in both the quarter and the first nine months, excluding those from the Jingzhou old site. In the first nine months of this year, ADAMA has launched 12 new products in China, driving this strong growth. Two new registrations of theNIMITZ® suite of products were obtained in the quarter. Anpon delivered a solid performance. The third quarter saw robust growth in Japan and a resilient performance in Australia, despite the continued severe drought in the country which is significantly reducing summer crops. These compensated for the weather-related challenges seen throughout South-East Asia.
During the quarter, the Company obtained new registrations in Australia, includingSOPRANO®, a cereal fungicide, andSOMBRERO®, an insecticide seed dressing for a wide range of crops. In US dollar terms, sales in Asia-Pacific grew by5.3% in the third quarter and by1.9% in the first nine months, compared to the corresponding periods last year, reflecting the impact of softer currencies.
India, Middle East& Africa: Sales in the third quarter were lower by3.4%, yet still grew by2.3% in the first nine months, in constant currency terms, compared to the corresponding periods last year.
In India, the Company benefited from the start of the monsoon rains, but was impacted by shortages of key products produced at the Jingzhou old site. ADAMA saw noteworthy sales in the country ofSHAMIR®, the novel dual-action combination fungicide for protection of multiple fruit and vegetable crops.
Over the nine-month period, India and Turkey delivered noteworthy performance.
In US dollar terms, sales were lower by4.0% in the third quarter and by2.4% in the first nine months, compared to the corresponding periods last year, reflecting the impact of softer currencies.
Table 3. Revenues by operating segment
Third quarter sales
|||
|-|-|
|Q3 2019||
||%|
|USD(m)||

|||
|-|-|
|Q3 2018||
||%|
|USD(m)||

Crop Protection 855 89.6% 812 93.0% Intermediates and Ingredients 99 10.4% 61 7.0% Total 953 100.0% 872 100.0% Nine months sales
|||
|-|-|
|9M 2019||
||%|
|USD(m)||

|||
|-|-|
|9M 2018||
||%|
|USD(m)||

Crop Protection 2,669 90.1% 2,717 93.1% Intermediates and Ingredients 293 9.9% 202 6.9% Total 2,962 100.0% 2,918 100.0% Further Information
All filings of the Company, together with a presentation of the key financial highlights of the period, can be accessed through the Company website at www.adama.com.
##
About ADAMA
ADAMA Ltd. is one of the world's leading crop protection companies. We strive to Create Simplicity in Agriculture– offering farmers effective products and services that simplify their lives and help them grow. With one of the most comprehensive and diversified portfolios of differentiated, quality products, our more than 7,000-strong team reaches farmers in over 100 countries, providing them with solutions to control weeds, insects and disease, and improve their yields. For more information, visit us at www.ADAMA.com and follow us onTwitter® at@ADAMAAgri.
Contact
Ben Cohen Zhujun Wang
Global Investor Relations China Investor Relations
Email:ir@adama.com Email:irchina@adama.com
Abridged Consolidated Financial Statements
The following abridged consolidated financial statements and notes have been prepared as described in Note 1. While prepared based on the principles of PRC GAAP, they do not contain all of the information which either PRC GAAP or IFRS would require for a complete set of financial statements and should be read in conjunction with the consolidated financial statements of both ADAMA Ltd. and Adama Agricultural Solutions Ltd. as filed with the Shenzhen and Tel Aviv Stock Exchanges, respectively.
Table 4. Abridged Consolidated Income Statement for the Third Quarter
||||||
|-|-|-|-|-|
||Q3 2019USD(m)|Q3 2018|Q3 2019|Q3 2018|
|Adjusted1|||||
|||USD(m)|RMB(m)|RMB(m)|

 Revenues 953 872 6,666 5,929 Cost of Sales 656 592 4,583 4,021 Business taxes and surcharges 3 2 18 12 Gross profit 295 279 2,064 1,896% of revenue 31.0% 32.0% 31.0% 32.0% Selling and distribution expenses 841 841 1,035 994 General and administrative expenses 32 30 225 202 Research and development expenses 81 81 108 107 Other operating expenses / (income) 17 6 115 43 Total Operating expenses 212 198 1,483 1,346 Operating income (EBIT) 83 81 581 550% of revenue 8.7% 9.3% 8.7% 9.3% Financial expenses and investment income 35 30 244 203 Income before taxes 48 51 337 347 Taxes on Income 6 11 41 73 Net income 42 40 296 273% of revenue 4.4% 4.6% 4.4% 4.6% EBITDA 144 134 1,010 909% of revenue 15.1% 15.3% 15.1% 15.3% Earnings per Share– Basic 0.0173 0.0164 0.1210 0.1117– Diluted 0.0173 0.0164 0.1210 0.1117 Earnings per share are the same for basic and diluted. The number of shares used to calculate earnings per share is 2,446.6 million shares.
1
For an analysis of the differences between the adjusted income statement items and the income statement items as reported in the
financial statements, see below “Analysis of Gaps between Adjusted Income Statement and Income Statement in Financial Statements”.
Table 5. Abridged Consolidated Income Statement for the Nine Months
||||||
|-|-|-|-|-|
||9M 2019USD(m)|9M 2018|9M 2019|9M 2018|
|Adjusted2|||||
|||USD(m)|RMB(m)|RMB(m)|

 Revenues 2,962 2,918 20,282 18,955 Cost of Sales 1,984 1,938 13,593 12,592 Business taxes and surcharges 9 8.4 65 54 Gross profit 968 972 6,624 6,308% of revenue 32.7% 33.3% 32.7% 33.3% Selling and distribution expenses 472 465 3,230 3,024 General and administrative expenses 101 103 690 671 Research and development expenses 46 40 318 263 Other operating expenses / (income) 24 10 164 65 Total Operating expenses 643 618 4,402 4,023 Operating income (EBIT) 325 353 2,222 2,285% of revenue 11.0% 12.1% 11.0% 12.1% Financial expenses and investment income 122 97 833 630 Income before taxes 204 257 1,389 1,656 Taxes on Income 30 59 206 384 Net income 173 197 1,183 1,272% of revenue 5.9% 6.8% 5.9% 6.8% EBITDA 509 512 3,481 3,321% of revenue 17.2% 17.6% 17.2% 17.6% Earnings per Share– Basic 0.0708 0.0806 0.4836 0.5200– Diluted 0.0708 0.0806 0.4836 0.5200 Earnings per share are the same for basic and diluted. The number of shares used to calculate earnings per share is 2,446.6 million shares.
2
For an analysis of the differences between the adjusted income statement items and the income statement items as reported in the
financial statements, see below “Analysis of Gaps between Adjusted Income Statement and Income Statement in Financial Statements”.
Table 6. Abridged Consolidated Balance Sheet
|||||
|-|-|-|-|
|September 30|September 30|September 30|September 30|
|2019|2018|2019|2018|
|USD (m)|USD (m)|RMB (m)|RMB (m)|

 Assets
Current assets:
Cash at bank and on hand 647 933 4,579 6,416 Bills and accounts receivable 1,214 1,045 8,585 7,189 Inventories 1,485 1,296 10,509 8,918 Other current assets, receivables and
307 243 2,171 1,674 prepaid expenses
Total current assets 3,653 3,517 25,844 24,197 Non-current assets:
Fixed assets, net 1,112 1,052 7,866 7,237 Rights of use assets 78 - 550 - Intangible assets, net 1,447 1,453 10,235 9,996 Deferred tax assets 111 98 782 673 Other non-current assets 109 76 771 525 Total non-current assets 2,857 2,679 20,203 18,431 Total assets 6,510 6,197 46,047 42,628 Liabilities
Current liabilities:
Loans and credit from banks and
298 136 2,106 936 others
Bills and accounts payable 581 610 4,109 4,195 Other current liabilities 707 791 5,002 5,443 Total current liabilities 1,586 1,537 11,218 10,574 Long-term liabilities:
Long-term loans 141 44 998 305 Debentures 1,206 1,151 8,533 7,915 Deferred tax liabilities 52 63 368 431 Employee benefits 102 93 719 637 Other long-term liabilities 140 50 989 343 Total long-term liabilities 1,641 1,400 11,607 9,631 Total liabilities 3,227 2,937 22,825 20,205 Equity
Total equity 3,283 3,260 23,222 22,423 Total equity 3,283 3,260 23,222 22,423 Total liabilities and equity 6,510 6,197 46,047 42,628
Table 7. Abridged Consolidated Cash Flow Statement for the Third Quarter
|||||
|-|-|-|-|
|Q3 2019|Q3 2018|Q3 2019|Q3 2018|
|USD (m)|USD (m)|RMB (m)|RMB (m)|

 Cash flow from operating activities:
Cash flow from operating activities 57 99 399 675 Cash flow from operating activities 57 99 399 675 Investing activities:
Acquisitions of fixed and intangible assets -69 -42 -484 -288 Proceeds from sale of long term assets 26 - 182 - Other investing activities 1 -2 10 -10 Cash flow used for investing activities -42 -44 -292 -298 Financing activities:
Receipt of loans from banks and other lenders 97 12 680 85 Repayment of loans from banks and other lenders -146 -10 -1,020 -68 Other financing activities -97 -33 -681 -218 Cash flow from (used for) financing activities -146 -30 -1,020 -201 Effects of exchange rate movement on cash and cash -8 -9 87 174 equivalents
Net change in cash and cash equivalents -139 16 -827 350 Cash and cash equivalents at the beginning of the period 783 910 5,382 6,021 Cash and cash equivalents at the end of the period 644 926 4,555 6,371 Free Cash Flow 7 52 44 352
Table 8. Abridged Consolidated Cash Flow Statement for the Nine Month
|||||
|-|-|-|-|
|9M 2019|9M 2018|9M 2019|9M 2018|
|USD (m)|USD (m)|RMB (m)|RMB (m)|

 Cash flow from operating activities:
Cash flow from operating activities 10 221 94 1,455 Cash flow from operating activities 10 221 94 1,455 Investing activities:
Acquisitions of fixed and intangible assets -158 -463 -1,090 -2,966 Proceeds received from disposal of investments 3 - 20 - Proceeds from sale of long term assets 33 380 235 2,413 Acquisitions of a subsidiary -123 - -827 - Other investing activities - -1 - -10 Cash flow used for investing activities -245 -85 -1,662 -563 Financing activities:
Receipt of loans from banks and other lenders 391 12 2,668 85 Repayment of loans from banks and other lenders -214 -332 -1,484 -2,116 Other financing activities -214 -81 -1,469 -526 Cash flow from (used for) financing activities -37 -401 -285 -2,557 Effects of exchange rate movement on cash and cash -9 -13 62 -172 equivalents
Net change in cash and cash equivalents -281 -277 -1,791 -1,493 Cash and cash equivalents at the beginning of the period 925 1,204 6,346 7,864 Cash and cash equivalents at the end of the period 644 926 4,555 6,371 Free Cash Flow -290 93 -1,952 616
Notes to Abridged Consolidated Financial Statements
Note 1: Basis of preparation
Basis of presentation and accounting policies: The abridged consolidated financial statements for the quarters ended September 30, 2019 and 2018 incorporate the financial statements of ADAMA Ltd. and of all of its subsidiaries (the “Company”), including Adama Agricultural Solutions Ltd. (“Solutions”) and its subsidiaries.
The Company has adopted the Accounting Standards for Business Enterprises issued by the Ministry of Finance (the "MoF") and the implementation guidance, interpretations and other relevant provisions issued or revised subsequently by the MoF (collectively referred to as "CASBE").
The abridged consolidated financial statements contained in this release are presented in both Chinese Renminbi (RMB), as theCompany’s shares are traded on the Shenzhen Stock Exchange, as well as in United States dollars($) as this is the major currency in which theCompany’s business is conducted. For the purposes of this release, a customary convenience translation has been used for the translation from RMB to US dollars, with Income Statement and Cash Flow items being translated using the quarterly average exchange rate, and Balance Sheet items being translated using the exchange rate at the end of the period. The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimated.
The 2018 figures are as previously reported, and not restated to include the business combination under common control in respect of Anpon.
In estimating the impact from the Jingzhou old site disruption, the lost sales and gross profit are calculated as the difference in sales and gross profit earned on the affected products between the relevant periods in 2019 and their comparative periods in 2018. Related operating expenses include idleness costs, as well as an assumed saving of2.5% of affected sales in respect of incremental Sales& Marketing expenses. Financing costs were assumed not to be impacted. An effective tax rate of20% was assumed in calculating the after-tax impact.
Note 2: Abridged Financial Statements
For ease of use, the Financial Statements shown in this release have been abridged as follows:
Abridged Consolidated Income Statement:
 “Other operating expenses/(income)” includes asset and credit impairment losses; gain (loss) from disposal of assets and non-operating income and expenses and idleness
 “Financial expenses and investment income” includes net financing expenses; gains from changes in fair value; and investment income (including share of income of equity accounted investees)
Abridged Consolidated Balance Sheet:
 “Other current assets, receivables and prepaid expenses” includes financial assets held for trading, derivatives financial assets, receivables financing, prepayments, other receivables; and other current assets
 “Fixed assets, net” includes fixed assets, construction in progress and rights-of-use assets
 “Intangible assets, net” includes intangible assets and goodwill
 “Other non-current assets” includes other equity investments; long-term equity investments; long-term receivables; investment property; and other non-current assets
 “Loans and credit from banks and others” includes short-term loans and non-current liabilities due within one year
 “Other current liabilities” includes derivatives financial liabilities, payables for employee benefits, contract liabilities, taxes payable, other payables and other current liabilities
 “Other long-term liabilities” includes long-term payables, lease liability, provisions and other non-
current liabilities
Table 9. Analysis of Gaps between Adjusted Income Statement and Reported Income Statement in Financial Statements
||||||||
|-|-|-|-|-|-|-|
|Q3|Adjusted||Adjustments||Reported||
|USD(m)|Q3 2019|Q3 2018|Q3 2019|Q3 2018|Q3 2019|Q3 2018|

 Revenues 953 872 - - 953 872 Gross profit 295 279 0 -0 295 279 Operating expenses 212 198 -15 -16 227 214 Operating income (EBIT) 83 81 15 16 68 65 Income before taxes 48 51 15 16 33 35 Net income 42 40 13 14 29 26 EBITDA 144 134 -8 -6 152 140 Earnings per share 0.0173 0.0164 0.1200 0.0108
||||||||
|-|-|-|-|-|-|-|
|Q3|Adjusted||Adjustments||Reported||
|RMB(m)|Q3 2019|Q3 2018|Q3 2019|Q3 2018|Q3 2019|Q3 2018|

 Revenues 6,666 5,929 - - 6,666 5,929 Gross profit 2,064 1,896 1 -2 2,063 1,897 Operating expenses 1,483 1,346 -103 -109 1,586 1,454 Operating income (EBIT) 581 550 104 107 477 443 Income before taxes 337 347 104 107 233 240 Net income 296 273 90 94 206 180 EBITDA 1,010 909 -54 -40 1,064 949 Earnings per share 0.1210 0.1117 0.0842 0.0734
||||||||
|-|-|-|-|-|-|-|
|9M|Adjusted||Adjustments||Reported||
|USD(m)|9M 2019|9M 2018|9M 2019|9M 2018|9M 2019|9M 2018|

 Revenues 2,962 2,918 - - 2,962 2,918 Gross profit 968 972 2 1 966 970 Operating expenses 643 618 -64 266 706 353 Operating income (EBIT) 325 353 66 -264 260 618 Income before taxes 204 257 63 -264 141 521 Net income 173 197 57 -201 116 398 EBITDA 509 512 -6 -317 515 829 Earnings per share 0.0708 0.0806 0.0476 0.1626
||||||||
|-|-|-|-|-|-|-|
|9M|Adjusted||Adjustments||Reported||
|RMB(m)|9M 2019|9M 2018|9M 2019|9M 2018|9M 2019|9M 2018|

 Revenues 20,282 18,955 - - 20,282 18,955 Gross profit 6,624 6,308 14 8 6,610 6,300 Operating expenses 4,402 4,023 -433 1,682 4,835 2,341 Operating income (EBIT) 2,222 2,285 448 -1,674 1,775 3,959 Income before taxes 1,389 1,656 427 -1,674 962 3,330 Net income 1,183 1,272 388 -1,270 795 2,542 EBITDA 3,481 3,321 -43 -2,015 3,524 5,336 Earnings per share 0.4836 0.5200 0.3248 1.0392
Table 10. Income Statement Adjustments
In addition to the reported financial results that the Company prepares in accordance with PRC GAAP, theCompany’s management prepares non-GAAP, Adjusted financial results to present what the Company believes is a more useful view of the true economic performance of the business on an ongoing basis. These Adjusted results exclude items that are of a one-time or non-cash/non-operational nature that do not impact the ongoing performance of the business and reflects the way theCompany’s management and Board of Directors view the performance of the Company. The Company believes that excluding the effects of these items from its operating results allows an effective assessment and comparison of the underlying financial performance of its business from period to period and within the market.
|||||
|-|-|-|-|
|Q3 2019USD (m)|Q3 2018|Q3 2019RMB (m)|Q3 2018RMB (m)|
||USD (m)|||

 Net Income (Reported) 29.5 26.4 206.1 179.7 Adjustments to COGS& Operating Expenses:
1. Amortization of Legacy PPA of 2011 acquisition of Solutions (non- 11.5 11.5 80.1 77.8 cash)
2. One-time capital gain from Divestment of registrations due to 2017 - - - - ChemChina-Syngenta transaction
3. Amortization of Transfer assets received and written-up due to 2017 7.7 10.2 53.5 69.2 ChemChina-Syngenta transaction (non-cash)
4. Reinstatement of amortization expenses due to Divestment (non- - - - - cash)
5. Accelerated depreciation due to relocation (non-cash) 1.6 - 11.2 - 6. Non-core assets closure (non-cash) - - - - 7. Long-term incentive (non-cash) -7.8 -5.9 -54.3 -40.1 8. Amortization of acquisition PPA (non-cash) 1.9 - 13.4 - 9. Sanonda-ADAMA Combination transaction one-time stamp tax - - - - Total Adjustments to Operating Income (EBIT) 14.9 15.7 103.9 106.9 Total Adjustments to EBITDA -7.7 -5.9 -53.7 -40.1 Adjustments to Financing Expenses:
10. Revaluation of non-cash adjustment related to non-controlling - - - - interest
Total Adjustments to Income before Taxes 14.9 15.7 103.9 106.9 Adjustments to Taxes
1. Tax shield on Legacy PPA of 2011 acquisition of Solutions 1.9 1.9 13.6 13.2 2. Tax expense due to capital gain from registrations Divestment - - - - 8. Deferred tax due to PPA 0.1 - 0.5 - Total adjustments to Net Income 12.8 13.8 89.8 93.7 Net Income (Adjusted) 42.3 40.2 296.0 273.4
|||||
|-|-|-|-|
|9M 2019|9M 2018|9M 2019|9M 2018|
|USD (m)|USD (m)|RMB (m)|RMB (m)|

 Net Income (Reported) 116.4 397.9 794.7 2,542.4 Adjustments to COGS& Operating Expenses:
1. Amortization of Legacy PPA of 2011 acquisition of Solutions (non- 34.4 34.4 235.4 223.7 cash)
2. One-time capital gain from Divestment of registrations due to 2017 - -314.3 - -1,998.5 ChemChina-Syngenta transaction
3. Amortization of Transfer assets received and written-up due to 2017 27.5 20.3 187.7 134.0 ChemChina-Syngenta transaction (non-cash)
4. Reinstatement of amortization expenses due to Divestment (non- - -2.6 - -16.5 cash)
5. Accelerated depreciation due to relocation (non-cash) 6.1 - 41.9 - 6. Non-core assets closure (non-cash) - 2.3 - 14.8 7. Long-term incentive (non-cash) -6.4 -6.0 -45.0 -41.0 8. Amortization of acquisition PPA (non-cash) 4.0 - 27.5 - 9. Sanonda-ADAMA Combination transaction one-time stamp tax - 1.5 - 9.4 Total Adjustments to Operating Income (EBIT) 65.6 -264.5 447.5 -1,674.0 Total Adjustments to EBITDA -6.1 -316.8 -43.4 -2,016.8 Adjustments to Financing Expenses:
10. Revaluation of non-cash adjustment related to non-controlling -3.0 - -20.5 - interest
Total Adjustments to Income before Taxes 62.5 -264.5 427.0 -1,674.0 Adjustments to Taxes
1. Tax shield on Legacy PPA of 2011 acquisition of Solutions 5.8 5.8 40.0 38.0 2. Tax expense due to capital gain from registrations Divestment - -69.5 - -441.8 8. Deferred tax due to PPA -0.2 - -1.4 - Total adjustments to Net Income 56.9 -200.8 388.3 -1,270.2 Net Income (Adjusted) 173.3 197.1 1,183.1 1,272.2 Notes:
1. Amortization of Legacy PPA of 2011 acquisition of Solutions (non-cash): Under PRC GAAP, the Company has inherited the historical “legacy” amortization charge from the first combined reporting for Q3 2017 that ChemChina previously was incurring in respect of its acquisition of Solutions in 2011. This amortization is done in a linear manner on a quarterly basis, most of which will be completed and removed in the second half of 2020.
2. One-time capital gain from Divestment of registrations due to 2017 ChemChina-Syngenta transaction: In the first quarter of 2018, the Company earned a one-time profit on the Divestment of crop protection products in connection with the approval by the EU Commission of the acquisition of Syngenta by ChemChina. This one-time profit is excluded from the Adjusted financial results due to its one-time nature, while the related tax expense is also adjusted for.
3. Amortization of Transfer assets received and written-up due to 2017 ChemChina-Syngenta transaction (non-cash): The proceeds from the Divestment of crop protection products in connection with the approval by the EU Commission of the acquisition of Syngenta by ChemChina, net of taxes and transaction expenses, were paid to Syngenta in return for the transfer of a portfolio of products in Europe of similar nature and economic value. Since the products acquired from Syngenta are of the same nature and with the same net economic value as those divested, and since the Company excludes the one-time gain that it made on the divested products, the additional amortization charge incurred due to the written-up of the acquired assets is also excluded to present a consistent view of Divestment and Transfer transactions, which had no net impact on the underlying economic performance of the Company. See note 2.
4. Reinstatement of amortization expenses, related to the Divestment (non-cash): Reinstatement of amortization expenses due to classification of to-be-divested European registrations as “Held-for-Sale”, related to 2017 ChemChina acquisition of Syngenta.
5. Accelerated depreciation due to relocation (non-cash): Production assets located in the old production sites in Jingzhou andHuai’An will be relocated to the new sites in the coming years. Since some of the older production assets may not be able to be relocated, some of these
assets which are no longer operational are being written off (or impaired), while for others, their economic life has been shortened and
therefore will be depreciated over a shorter period. Since these are older assets that were built many years ago and will be replaced by newer
production facilities at the new sites, and since the ongoing operations of the business will not be impacted thereby, the Company adjusts for
the impact of the accelerated depreciation of these assets.
6. Non-core assets closure (non-cash): One-time charge due to closure of peripheral, non-material assets.
7. Long-term Incentive (non-cash): The Company granted its employees, who are mainly non-Chinese residents, a long term incentive (LTI) in
the form of 'phantom' options, due to the complexity of granting Chinese-listed, equity-settled options to non-Chinese employees. As such, the Company records an expense, or recognizes income, depending on the fluctuation in theCompany’s share price, even though the Company will not incur any cash impact prior to exercise of the phantom options. To neutralize the impact of such share price movements on the measurement of theCompany’s performance and expected employee compensation and to reflect the existing phantom options, in theCompany’s adjusted financial performance, the LTI is presented on an equity-settled basis in accordance with the value of the existing plan at the grant date.
8. Amortization of acquisition PPA (non-cash): Related to the amortization of non-cash intangible assets created as part of acquisitions; has no impact on the ongoing performance of the companies acquired.
9. Sanonda-ADAMA Combination transaction one-time stamp tax: One-time stamp tax expense incurred related to the Combination. 10. Revaluation of non-cash adjustment related to non-controlling interest: Relates to put options issued to non-controlling interests as part of historical business combinations which took place before January 1, 2010. The put options are presented as a liability at the present value of the future exercise price. The revaluation of these put options in Solutions is recognized under IFRS to Goodwill, but due to the acquisition of Solutions by the Company in 2017, which is treated from an accounting perspective as a “Business Combination Under Common Control”, such revaluation is recorded as a profit or loss item in the financial reports of the Company. The revaluations of such put options have no bearing on the ongoing performance of the Company and are therefore adjusted for.
Table 11. Exchange Rate Data for the Company's Principal
Functional Currencies
||||||||||
|-|-|-|-|-|-|-|-|-|
|September 30|||Q3 Average|||9M Average|||
|2019|2018|Change|2019|2018|Change|2019|2018|Change|

 EUR/USD 1.093 1.162 (6.0%) 1.112 1.163 (4.4%) 1.124 1.194 (5.9%) USD/BRL 4.164 4.004 (4.0%) 3.974 3.958 (0.4%) 3.888 3.603 (7.9%) USD/PLN 4.000 3.675 (8.8%) 3.885 3.704 (4.9%) 3.829 3.559 (7.6%) USD/ZAR 15.083 14.182 (6.4%) 14.677 14.105 (4.1%) 14.367 12.891(11.5%) AUD/USD 0.676 0.721 (6.3%) 0.686 0.731 (6.3%) 0.699 0.758 (7.7%) GBP/USD 1.229 1.306 (5.9%) 1.232 1.303 (5.4%) 1.273 1.351 (5.8%) USD/ILS 3.482 3.627 4.0% 3.527 3.631 2.9% 3.589 3.553 (1.0%) USD LIBOR 3M 2.09% 2.40%(13.1%) 2.20% 3.24%(6.0%) 2.46% 3.89% 12.4%
||||||||||
|-|-|-|-|-|-|-|-|-|
|September 30|||Q3 Average|||9M Average|||
|2019|2018|Change|2019|2018|Change|2019|2018|Change|

 USD/RMB 7.073 6.879 2.8% 6.992 6.797 2.9% 6.851 6.511 5.2% EUR/RMB 7.729 7.996 (3.3%) 7.774 7.903 (1.6%) 7.699 7.776 (1.0%) RMB/BRL 0.589 0.582 (1.2%) 0.568 0.582 2.4% 0.567 0.553 (2.6%) RMB/PLN 0.566 0.534 (5.9%) 0.556 0.545 (2.0%) 0.559 0.547 (2.2%) RMB/ZAR 2.133 2.062 (3.4%) 2.099 2.075 (1.2%) 2.097 1.980 (5.9%) AUD/RMB 4.783 4.963 (3.6%) 4.793 4.971 (3.6%) 4.791 4.933 (2.9%) GBP/RMB 8.694 8.987 (3.3%) 8.615 8.857 (2.7%) 8.718 8.795 (0.9%) RMB/ILS 0.492 0.527 6.6% 0.504 0.534 5.6% 0.524 0.546 4.0% RMB SHIBOR 3M 2.73% 2.85% (4.2%) 2.67% 3.11%(14.2%) 2.80% 3.98%(29.6%)